Literature DB >> 24682263

Thoc1 inhibits cell growth via induction of cell cycle arrest and apoptosis in lung cancer cells.

Jianmei Wan1, Shitao Zou2, Mengshang Hu3, Ran Zhu1, Jiaying Xu1, Yang Jiao1, Saijun Fan1.   

Abstract

THO complex 1 (Thoc1) is a human nuclear matrix protein that binds to the retinoblastoma tumor suppressor retinoblastoma protein (pRb). While some studies suggest that Thoc1 has characteristics of a tumor suppressor protein, whether Thoc1 can inhibit lung cancer cell growth is not clear. In the present study, we observed that Thoc1 is lowly expressed in the lung cancer cell lines SPC-A1 and NCI-H1975. Then, we investigated the potential effects of Thoc1 on lung cancer cell proliferation, cell cycle and apoptosis after stable transfection of these lines with a Thoc1 expression vector. We found that overexpression of Thoc1 can inhibit cell proliferation, induce G2/M cell cycle arrest and promote apoptosis. Further investigation indicated that overexpression of Thoc1 is involved in the inhibition of cell cycle-related proteins cyclin A1 and B1 and of pro-apoptotic factors Bax and caspase-3. In vivo experiments showed that tumors overexpressing Thoc1 display a slower growth rate than the control xenografts and show reduced expression of the protein Ki-67, which localized on the nuclear membrane. Taken together, our data show that in lung cancer cells, Thoc1 inhibits cell growth through induction of cell cycle arrest and apoptosis. These results indicate that Thoc1 may be used as a novel therapeutic target for human lung cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24682263     DOI: 10.3892/mmr.2014.2088

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

1.  Deep sequencing of the mouse lung transcriptome reveals distinct long non-coding RNAs expression associated with the high virulence of H5N1 avian influenza virus in mice.

Authors:  Jiao Hu; Zenglei Hu; Xiaoquan Wang; Min Gu; Zhao Gao; Yanyan Liang; Chunxi Ma; Xiaowen Liu; Shunlin Hu; Sujuan Chen; Daxing Peng; Xinan Jiao; Xiufan Liu
Journal:  Virulence       Date:  2018       Impact factor: 5.882

2.  Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis.

Authors:  Zhenhua Li; Meixiang Sang; Ziqiang Tian; Zhao Liu; Jian Lv; Fan Zhang; Baoen Shan
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

3.  Screening and Identification of Survival-Associated Splicing Factors in Lung Squamous Cell Carcinoma.

Authors:  Min Chen; Rui Zhu; Fangzhou Zhang; Liucun Zhu
Journal:  Front Genet       Date:  2022-01-20       Impact factor: 4.599

4.  The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies.

Authors:  Michal Kovac; Baptiste Ameline; Sebastian Ribi; Monika Kovacova; William Cross; Maxim Barenboim; Olaf Witt; Stefan Bielack; Andreas Krieg; Wolfgang Hartmann; Michaela Nathrath; Daniel Baumhoer
Journal:  J Pathol       Date:  2021-05-25       Impact factor: 7.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.